149: Intestinal transplantation for intestinal motility disorders

医学 移植 入射(几何) 胃肠病学 内科学 回顾性队列研究 尸体痉挛 短肠综合征 外科 儿科 肠外营养 光学 物理
作者
Hironori Kudo,Ryo Ando,Tsuyoshi Sakurai,Keisuke Tada,H. Sasaki,Taichi Fukuzawa,Ryuji Okubo,Masatoshi Hashimoto,Kosuke Sato,Motoshi Wada
出处
期刊:Transplantation [Ovid Technologies (Wolters Kluwer)]
卷期号:107 (7S): 86-86
标识
DOI:10.1097/01.tp.0000946052.51104.04
摘要

Introduction: Intestinal mobility disorder (MD) is a major cause of severe intestinal failure requiring intestinal transplantation (ITx), especially in Asian countries. This study aimed to assess the outcome of ITx for patients with MD. Methods: Between 2003 and 2022, 11 patients underwent ITx at our institution. Underlying MD was identified in eight patients, and short gut syndrome in the remaining three. Patients with MD were divided into two groups according to Era: Era I (2003-2010, n=4) and Era II (2011-2022, n=4). A retrospective review was performed to evaluate the patient characteristics, operative data, patient and graft-survival rates, and incidence of complications, including acute rejection (AR). Results: Patient’s age at the time of primary ITx in Era I was higher than in Era II (median, 20 years vs. 15 years). In Era I, hypoganglionosis (n=2) and chronic idiopathic intestinal pseudo-obstruction (CIIPS) (n=2) were diagnosed, while in Era II, hypoganglionosis (n=1), CIIPS (n=1), megacystis microcolon intestinal hypoperistalsis syndrome (n=1), and extensive aganglionosis (n=1). An induction immunosuppressive treatment included an interleukin-2 receptor antagonist in Era I and rabbit antithymocyte globulin in Era II. Furthermore, the donor type was living (n=2) and cadaveric (n=2) in Era I and all cadaveric (n=4) in Era II. Median durations of follow-up after ITx were 102 and 81 months in Era I and II, respectively. One-, 5-, and 10-year patient survival rates were 100%, 75%, and 44.4% in Era I and 100%, 100%, and 100% in Era II, respectively (p=0.1). Three patients in Era I died: one due to sepsis, another due to abdominal bleeding, and the other due to acute pancreatitis. In comparison, 1-, 5-, and 10-year graft survival rates were 75%, 50%, and 25% in Era I and 100%, 100%, and 100% in Era II, respectively (p=0.07). The incidences of moderate or severe AR and medical complication including renal deficiency and diabetes mellitus, were 100% and 50%, respectively, in Era I and 50% and 75%, respectively, in Era II. Three patients (one in Era I; two in Era II) were completely weaned from parenteral nutrition. Conclusions: The ages and underlying disease of patients had enlarged by Era. Although patient- and graft-survival rates in Era II were superior to those in Era I, the incidence of AR and medical complications were similar between Era.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava应助假面绅士采纳,获得30
刚刚
研友_nPPzon发布了新的文献求助10
刚刚
灯火完成签到,获得积分10
1秒前
2秒前
LIVE给LIVE的求助进行了留言
3秒前
善学以致用应助yoyo采纳,获得10
4秒前
STR发布了新的文献求助10
5秒前
8秒前
科研通AI2S应助辰星采纳,获得10
8秒前
FashionBoy应助结实雁山采纳,获得10
10秒前
juziyaya应助一叶知秋采纳,获得30
10秒前
芋鱼予郁应助假面绅士采纳,获得10
10秒前
czp完成签到,获得积分10
11秒前
13秒前
14秒前
czp发布了新的文献求助10
14秒前
14秒前
兴奋大地完成签到,获得积分10
15秒前
yoyo发布了新的文献求助10
17秒前
1中蓝完成签到 ,获得积分10
17秒前
来了来了发布了新的文献求助10
18秒前
奔奔发布了新的文献求助10
20秒前
22秒前
成梦完成签到,获得积分10
23秒前
书晴完成签到,获得积分10
25秒前
28秒前
梵高发布了新的文献求助10
28秒前
29秒前
30秒前
31秒前
32秒前
mol发布了新的文献求助10
32秒前
32秒前
33秒前
不配.应助假面绅士采纳,获得10
33秒前
标致冰海发布了新的文献求助10
35秒前
god之hand发布了新的文献求助10
35秒前
NIKO发布了新的文献求助10
36秒前
日尧完成签到,获得积分10
36秒前
顾矜应助御风采纳,获得10
37秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3141384
求助须知:如何正确求助?哪些是违规求助? 2792400
关于积分的说明 7802329
捐赠科研通 2448585
什么是DOI,文献DOI怎么找? 1302633
科研通“疑难数据库(出版商)”最低求助积分说明 626650
版权声明 601237